Arouse Plus

Arouse Plus Capsules Available in Pakistan

There may be a solution for women struggling with low sexual desire. Bremelanotide, also called Veleesi, is a new drug approved by the FDA to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is a condition where low sexual desire has no clear cause. Women interested in this medication should understand that it is not intended to address low desire stemming from physical or mental health problems, interpersonal conflicts, or side effects of other treatments.Dietary and organic food options for a balanced diet.

Ingredient

• Natural Ingredients
• Thermogenic
• Caffeine
• Green Tea Extract
• L-Theanine
• Safe Formula

Benefit

• Boost Energy
• Burn Fat
• Increase Metabolism
• Suppress Appetite
• Weight Management
• Enhanced Focus

The female physique has a complex mechanism behind sexual stimulation and yearning. Approximately 40% of women struggle with a diminished libido, with the figures fluctuating based on factors like age, location, and recent childbearing. Undoubtedly, this is a pressing concern for some.
The safety and effectiveness of bremelanotide were examined through a study sponsored by the medication’s manufacturer’s licensing partner. Over 1,200 participants were randomly assigned to receive either the drug or a dummy treatment for up to 24 weeks, as disclosed by the FDA.
Compared to 17% of placebo takers, nearly 25% of those given bremelanotide reported some increase in sexual desire. The study also evaluated the women’s distress regarding their lack of sexual appetite. Around 35% of bremelanotide recipients experienced some relief in their level of anguish, in contrast to 31% of placebo users. However, the drug did not impact the quantity of fulfilling sexual encounters.